Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 19/20 | 0.47 |
| ▸ | PIK3CA | P42336 | 16/20 | 0.47 |
| ▸ | MTOR | P42345 | 15/20 | 0.47 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.47 |
| ▸ | ATR | Q13535 | 6/20 | 0.46 |
| ▸ | PRKDC | P78527 | 2/20 | 0.46 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.46 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.46 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21851154 | 0.74 | ATM (0.59) | ATMPIK3CAMTORKCNH2ATR | |
| SCHEMBL23615882 | 0.73 | ATM (0.47) | ATMPIK3CAMTORKCNH2ATR | |
| SCHEMBL24772413 | 0.72 | ATM (0.57) | ATMPIK3CAMTORKCNH2ATR | |
| SCHEMBL19618853 | 0.67 | ATM (0.64) | ATMPIK3CAMTORKCNH2ATR | |
| SCHEMBL20006083 | 0.67 | ATM (0.64) | ATMPIK3CAMTORKCNH2ATR | |
| SCHEMBL21851114 | 0.67 | ATM (0.63) | ATMPIK3CAMTORKCNH2ATR | |
| SCHEMBL21851066 | 0.67 | ATM (0.51) | ATMPIK3CAMTORKCNH2ATR | |
| SCHEMBL29969843 | 0.66 | ATM (0.57) | ATMPIK3CAMTORKCNH2ATR | |
| SCHEMBL23634678 | 0.65 | ATM (0.74) | ATMPIK3CAMTORKCNH2ATR | |
| SCHEMBL23615883 | 0.65 | ATM (0.53) | ATMPIK3CAMTORKCNH2ATR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020063855-A1 | QUINOLINO-PYRROLIDIN-2-ONE DERIVATIVE AND APPLICATION THEREOF | 南京明德新药研发有限公司 | 2020-04-02 | — | — | WO | disclosed |